China Jianyin Investment (JIC), a long-term investor, has entered into exclusive discussions to acquire SGD Pharma. Jurgen Sackhoff, SGD Pharma President, welcomed the move, and said: "The combination with JIC will open exciting new growth opportunities for us in Asia." SGDs perfumery manufacturing business has been a separate company to SGD Pharma since 2015 and will not be affected the acquisition of SGD Pharma. The company operates five manufacturing sites - two in France, and one in Germany, India and China.
Origin
Unknown
Journal Title
Glass Int June 2016 4
Sector
News Items
Class
N 3623